How much revenue did Grifols generate this year?
Grifols has achieved a revenue of 7.4 B EUR this year.
Grifols Revenue 2024
Grifols Revenue
7.4 B EUR
Ticker
GRF.MC
ISIN
ES0171996087
WKN
A2ABUQ
In 2024, Grifols's sales reached 7.4 B EUR, a 12.18% difference from the 6.59 B EUR sales recorded in the previous year.
The Grifols Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 8.37 | 29,80 |
| 2028e | 8.82 | 28,28 |
| 2027e | 8.52 | 29,27 |
| 2026e | 8.2 | 30,42 |
| 2025e | 7.67 | 32,52 |
| 2024e | 7.4 | 33,73 |
| 2023 | 6.59 | 37,84 |
| 2022 | 6.06 | 36,80 |
| 2021 | 4.93 | 39,78 |
| 2020 | 5.34 | 42,23 |
| 2019 | 5.1 | 45,92 |
| 2018 | 4.49 | 45,68 |
| 2017 | 4.32 | 49,84 |
| 2016 | 4.05 | 47,22 |
| 2015 | 3.93 | 49,08 |
| 2014 | 3.36 | 50,64 |
| 2013 | 2.74 | 51,72 |
| 2012 | 2.62 | 50,73 |
| 2011 | 1.8 | 75,93 |
| 2010 | 0.99 | 77,05 |
| 2009 | 0.91 | 81,19 |
| 2008 | 0.82 | 81,67 |
| 2007 | 0.7 | 74,49 |
| 2006 | 0.65 | 68,68 |
| 2005 | 0.52 | 70,65 |
| 2004 | 0.46 | 71,74 |
Grifols Revenue, EBIT, Net Income ES0171996087 · A2ABUQ
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Grifols, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Grifols from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Grifols’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Grifols. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Grifols’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Grifols’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Grifols’s growth potential.
Grifols Revenue, EBIT and net profit per share
| Date | Grifols Revenue | Grifols EBIT | Grifols Net Income |
|---|---|---|---|
| 2029e | 8.37 B undefined | 0 undefined | 0 undefined |
| 2028e | 8.82 B undefined | 1.46 B undefined | 690.99 M undefined |
| 2027e | 8.52 B undefined | 1.72 B undefined | 660.16 M undefined |
| 2026e | 8.2 B undefined | 1.75 B undefined | 519.05 M undefined |
| 2025e | 7.67 B undefined | 1.55 B undefined | 418.31 M undefined |
| 2024e | 7.4 B undefined | 1.3 B undefined | 289.77 M undefined |
| 2023 | 6.59 B undefined | 735.66 M undefined | 59.32 M undefined |
| 2022 | 6.06 B undefined | 702.2 M undefined | 208.28 M undefined |
| 2021 | 4.93 B undefined | 562.51 M undefined | 188.73 M undefined |
| 2020 | 5.34 B undefined | 975.33 M undefined | 618.55 M undefined |
| 2019 | 5.1 B undefined | 1.12 B undefined | 625.15 M undefined |
| 2018 | 4.49 B undefined | 994.12 M undefined | 596.64 M undefined |
| 2017 | 4.32 B undefined | 1 B undefined | 662.7 M undefined |
| 2016 | 4.05 B undefined | 939.41 M undefined | 545.46 M undefined |
| 2015 | 3.93 B undefined | 970.37 M undefined | 532.15 M undefined |
| 2014 | 3.36 B undefined | 857.69 M undefined | 470.25 M undefined |
| 2013 | 2.74 B undefined | 736.1 M undefined | 345.6 M undefined |
| 2012 | 2.62 B undefined | 660.1 M undefined | 256.7 M undefined |
| 2011 | 1.8 B undefined | 355.8 M undefined | 50.3 M undefined |
| 2010 | 991.9 M undefined | 209.3 M undefined | 115.5 M undefined |
| 2009 | 914.6 M undefined | 226.5 M undefined | 148 M undefined |
| 2008 | 818 M undefined | 202 M undefined | 121.7 M undefined |
| 2007 | 703.3 M undefined | 146.4 M undefined | 87.8 M undefined |
| 2006 | 648.8 M undefined | 100.5 M undefined | 45.4 M undefined |
| 2005 | 524.3 M undefined | 73.6 M undefined | 25.6 M undefined |
| 2004 | 456.5 M undefined | 56.3 M undefined | 26.4 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 456.5 M EUR | 56.3 M EUR | 26.4 M EUR |
| 2005 | 524.3 M EUR | 73.6 M EUR | 25.6 M EUR |
| 2006 | 648.8 M EUR | 100.5 M EUR | 45.4 M EUR |
| 2007 | 703.3 M EUR | 146.4 M EUR | 87.8 M EUR |
| 2008 | 818 M EUR | 202 M EUR | 121.7 M EUR |
| 2009 | 914.6 M EUR | 226.5 M EUR | 148 M EUR |
| 2010 | 991.9 M EUR | 209.3 M EUR | 115.5 M EUR |
| 2011 | 1.8 B EUR | 355.8 M EUR | 50.3 M EUR |
| 2012 | 2.62 B EUR | 660.1 M EUR | 256.7 M EUR |
| 2013 | 2.74 B EUR | 736.1 M EUR | 345.6 M EUR |
| 2014 | 3.36 B EUR | 857.69 M EUR | 470.25 M EUR |
| 2015 | 3.93 B EUR | 970.37 M EUR | 532.15 M EUR |
| 2016 | 4.05 B EUR | 939.41 M EUR | 545.46 M EUR |
| 2017 | 4.32 B EUR | 1 B EUR | 662.7 M EUR |
| 2018 | 4.49 B EUR | 994.12 M EUR | 596.64 M EUR |
| 2019 | 5.1 B EUR | 1.12 B EUR | 625.15 M EUR |
| 2020 | 5.34 B EUR | 975.33 M EUR | 618.55 M EUR |
| 2021 | 4.93 B EUR | 562.51 M EUR | 188.73 M EUR |
| 2022 | 6.06 B EUR | 702.2 M EUR | 208.28 M EUR |
| 2023 | 6.59 B EUR | 735.66 M EUR | 59.32 M EUR |
| 2024e | 7.4 B EUR | 1.3 B EUR | 289.77 M EUR |
| 2025e | 7.67 B EUR | 1.55 B EUR | 418.31 M EUR |
| 2026e | 8.2 B EUR | 1.75 B EUR | 519.05 M EUR |
| 2027e | 8.52 B EUR | 1.72 B EUR | 660.16 M EUR |
| 2028e | 8.82 B EUR | 1.46 B EUR | 690.99 M EUR |
| 2029e | 8.37 B EUR | 0 EUR | 0 EUR |
Grifols stock margins ES0171996087 · A2ABUQ
The Grifols margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Grifols. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Grifols.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Grifols's sales revenue. A higher gross margin percentage indicates that the Grifols retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Grifols's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Grifols's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Grifols's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Grifols. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Grifols's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Grifols Margin History
| Grifols Gross margin | Grifols Profit margin | Grifols EBIT margin | Grifols Profit margin |
|---|---|---|---|
| 2029e | 37.84 % | 0 % | 0 % |
| 2028e | 37.84 % | 16.52 % | 7.83 % |
| 2027e | 37.84 % | 20.17 % | 7.74 % |
| 2026e | 37.84 % | 21.36 % | 6.33 % |
| 2025e | 37.84 % | 20.18 % | 5.45 % |
| 2024e | 37.84 % | 17.61 % | 3.92 % |
| 2023 | 37.84 % | 11.16 % | 0.9 % |
| 2022 | 36.8 % | 11.58 % | 3.43 % |
| 2021 | 39.78 % | 11.4 % | 3.83 % |
| 2020 | 42.23 % | 18.26 % | 11.58 % |
| 2019 | 45.92 % | 22.01 % | 12.26 % |
| 2018 | 45.68 % | 22.16 % | 13.3 % |
| 2017 | 49.84 % | 23.24 % | 15.35 % |
| 2016 | 47.22 % | 23.2 % | 13.47 % |
| 2015 | 49.08 % | 24.66 % | 13.52 % |
| 2014 | 50.64 % | 25.56 % | 14.01 % |
| 2013 | 51.72 % | 26.85 % | 12.61 % |
| 2012 | 50.73 % | 25.19 % | 9.79 % |
| 2011 | 75.93 % | 19.81 % | 2.8 % |
| 2010 | 77.05 % | 21.1 % | 11.64 % |
| 2009 | 81.19 % | 24.76 % | 16.18 % |
| 2008 | 81.67 % | 24.69 % | 14.88 % |
| 2007 | 74.49 % | 20.82 % | 12.48 % |
| 2006 | 68.68 % | 15.49 % | 7 % |
| 2005 | 70.65 % | 14.04 % | 4.88 % |
| 2004 | 71.74 % | 12.33 % | 5.78 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 71.74 % | 12.33 % | 5.78 % |
| 2005 | 70.65 % | 14.04 % | 4.88 % |
| 2006 | 68.68 % | 15.49 % | 7 % |
| 2007 | 74.49 % | 20.82 % | 12.48 % |
| 2008 | 81.67 % | 24.69 % | 14.88 % |
| 2009 | 81.19 % | 24.76 % | 16.18 % |
| 2010 | 77.05 % | 21.1 % | 11.64 % |
| 2011 | 75.93 % | 19.81 % | 2.8 % |
| 2012 | 50.73 % | 25.19 % | 9.79 % |
| 2013 | 51.72 % | 26.85 % | 12.61 % |
| 2014 | 50.64 % | 25.56 % | 14.01 % |
| 2015 | 49.08 % | 24.66 % | 13.52 % |
| 2016 | 47.22 % | 23.2 % | 13.47 % |
| 2017 | 49.84 % | 23.24 % | 15.35 % |
| 2018 | 45.68 % | 22.16 % | 13.3 % |
| 2019 | 45.92 % | 22.01 % | 12.26 % |
| 2020 | 42.23 % | 18.26 % | 11.58 % |
| 2021 | 39.78 % | 11.4 % | 3.83 % |
| 2022 | 36.8 % | 11.58 % | 3.43 % |
| 2023 | 37.84 % | 11.16 % | 0.9 % |
| 2024e | 37.84 % | 17.61 % | 3.92 % |
| 2025e | 37.84 % | 20.18 % | 5.45 % |
| 2026e | 37.84 % | 21.36 % | 6.33 % |
| 2027e | 37.84 % | 20.17 % | 7.74 % |
| 2028e | 37.84 % | 16.52 % | 7.83 % |
| 2029e | 37.84 % | 0 % | 0 % |
Grifols Aktienanalyse
What does Grifols do?
Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Grifols's Sales Figures
The sales figures of Grifols originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Grifols’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Grifols's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Grifols’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Grifols stock
How much was the turnover of the company Grifols compared to the previous year?
The revenue of Grifols has increased by 12.18% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Grifols?
The revenue of Grifols is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Grifols measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Grifols so important for investors?
The revenue of Grifols is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Grifols pay?
Over the past 12 months, Grifols paid a dividend of 0.36 EUR . This corresponds to a dividend yield of about 3.6 %. For the coming 12 months, Grifols is expected to pay a dividend of 0 EUR.
What is the dividend yield of Grifols?
The current dividend yield of Grifols is 3.6 %.
When does Grifols pay dividends?
Grifols pays a quarterly dividend. This is distributed in the months of July, January, November, July.
How secure is the dividend of Grifols?
Grifols paid dividends every year for the past 0 years.
What is the dividend of Grifols?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Grifols located?
Grifols is assigned to the 'Health' sector.
Wann musste ich die Aktien von Grifols kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Grifols from 6/7/2021 amounting to 0.364 EUR, you needed to have the stock in your portfolio before the ex-date on 6/3/2021.
When did Grifols pay the last dividend?
The last dividend was paid out on 6/7/2021.
What was the dividend of Grifols in the year 2023?
In the year 2023, Grifols distributed 0 EUR as dividends.
In which currency does Grifols pay out the dividend?
The dividends of Grifols are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Grifols
Our stock analysis for Grifols Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Grifols Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
